Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases.

Cosset E, Locatelli M, Marteyn A, Lescuyer P, Dall Antonia F, Mor FM, Preynat-Seauve O, Stoppini L, Tieng V.

J Vis Exp. 2019 Jun 28;(148). doi: 10.3791/59682.

PMID:
31305527
2.

Re-thinking the preclinical development of GBM therapeutics.

Cosset É, Weis SM, Cheresh DA.

Oncoscience. 2018 Feb 23;5(1-2):11-12. doi: 10.18632/oncoscience.396. eCollection 2018 Jan. No abstract available.

3.

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.

Cosset É, Ilmjärv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, Reiss A, Moroishi T, Seguin L, Gomez G, Moo JS, Preynat-Seauve O, Krause KH, Chneiweiss H, Sarkaria JN, Guan KL, Dietrich PY, Weis SM, Mischel PS, Cheresh DA.

Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30.

4.

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers.

Seguin L, Camargo MF, Wettersten HI, Kato S, Desgrosellier JS, von Schalscha T, Elliott KC, Cosset E, Lesperance J, Weis SM, Cheresh DA.

Cancer Discov. 2017 Dec;7(12):1464-1479. doi: 10.1158/2159-8290.CD-17-0539. Epub 2017 Sep 11.

5.

Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness.

Cosset E, Petty T, Dutoit V, Tirefort D, Otten-Hernandez P, Farinelli L, Dietrich PY, Preynat-Seauve O.

Biomaterials. 2016 Nov;107:74-87. doi: 10.1016/j.biomaterials.2016.08.009. Epub 2016 Aug 24.

PMID:
27614160
6.

Human three-dimensional engineered neural tissue reveals cellular and molecular events following cytomegalovirus infection.

Cosset É, Martinez Y, Preynat-Seauve O, Lobrinus JA, Tapparel C, Cordey S, Peterson H, Petty TJ, Colaianna M, Tieng V, Tirefort D, Dinnyes A, Dubois-Dauphin M, Kaiser L, Krause KH.

Biomaterials. 2015;53:296-308. doi: 10.1016/j.biomaterials.2015.02.094. Epub 2015 Mar 17.

PMID:
25890728
7.

Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response.

Cosset É, Petty TJ, Dutoit V, Cordey S, Padioleau I, Otten-Hernandez P, Farinelli L, Kaiser L, Bruyère-Cerdan P, Tirefort D, Amar El-Dusouqui S, Nayernia Z, Krause KH, Zdobnov EM, Dietrich PY, Rigal E, Preynat-Seauve O.

Int J Cancer. 2014 Sep 15;135(6):1381-9. doi: 10.1002/ijc.28670. Epub 2014 May 8.

8.

The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma.

Nayernia Z, Turchi L, Cosset E, Peterson H, Dutoit V, Dietrich PY, Tirefort D, Chneiweiss H, Lobrinus JA, Krause KH, Virolle T, Preynat-Seauve O.

Biomaterials. 2013 Nov;34(33):8279-90. doi: 10.1016/j.biomaterials.2013.07.006. Epub 2013 Jul 27.

PMID:
23899445
9.

Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.

Cosset EC, Godet J, Entz-Werlé N, Guérin E, Guenot D, Froelich S, Bonnet D, Pinel S, Plenat F, Chastagner P, Dontenwill M, Martin S.

Int J Cancer. 2012 Aug 1;131(3):601-11. doi: 10.1002/ijc.26415. Epub 2011 Oct 5.

10.

Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia.

Cosset E, Hamdan G, Jeanpierre S, Voeltzel T, Sagorny K, Hayette S, Mahon FX, Dumontet C, Puisieux A, Nicolini FE, Maguer-Satta V.

Blood. 2011 Feb 3;117(5):1673-6. doi: 10.1182/blood-2009-11-254680. Epub 2010 Dec 1.

PMID:
21123820
11.

Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist.

Martin S, Cosset EC, Terrand J, Maglott A, Takeda K, Dontenwill M.

Biochim Biophys Acta. 2009 Feb;1793(2):354-67. doi: 10.1016/j.bbamcr.2008.09.019. Epub 2008 Oct 17.

Supplemental Content

Loading ...
Support Center